PATENT CLAIM ANALYSIS

Application Number: 16438135
Application Type: Utility
Filing Date: 2019-06
Publication Date: 2019-10
Patent Classification: ["544", "281000"]

Abstract:
Compounds of Formula (00A) and methods of use as Janus kinase inhibitors are described herein.

Claim (Index 6):
The compound of  claim 1 , further defined as a compound of Formula (V): wherein:\n R 0e  is H or NH 2 ; \n R 1e  is selected from the group consisting of\n a. H, \n b. C 1 -C 6  alkyl optionally substituted by halo, CN, or phenyl, \n c. \u2014(C 1 -C 6  alkylene)-3-6 membered cycloalkyl wherein the cycloalkyl is optionally substituted by CN, \n d. \u2014(C 1 -C 6  alkylene)-4-6 membered heterocycloalkyl wherein the heterocycloalkyl is optionally substituted by C 1 -C 6  alkyl; \n \n R 2e  is H or C 1 -C 6  alkyl; \n or R 1e  and R 2e  together form a 3-11 membered heterocycloalkyl optionally substituted by halo or \u2014NR v R w , wherein R v  and R w  are independently H or C 1 -C 6  alkyl optionally substituted by halo; \n R 3e  is a bond or C 1 -C 6  alkylene optionally substituted by oxo; and \n Ring H is a 3-7 membered heterocycloalkyl wherein p 1e  is 0, 1 or 2 and p 2e  is 0, 1 or 2.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 100.0
- Lexical Diversity: 1.05882
- Patent Class: 544.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15139164', '15543826', '14904801', '14451600', '15257926']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8064705198090979
- 35 USC 102 Novelty (BERT): 0.5952729554529851
- Combined Prediction Score: 0.7853507633734866
- Mean Citation Score: 405.063252
- Max Citation Score: 495.0762
- Similarity Product: 489.9422223274112

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test